[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559509":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":34,"responsibleParty":64,"collaborators":18,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":71,"acronym":18,"eligibilityCriteria":72,"healthyVolunteers":69,"sex":73,"minAge":74,"maxAge":18,"enrollmentInfo":75,"targetDuration":18,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":87,"overallStatus":36,"whyStopped":18,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A: Prehabilitation Program","EXPERIMENTAL","Participants will be randomized in a 1:1 ratio using a permuted blocked design and stratified by neoadjuvant therapy received. Participants will complete the following:\n\n* In-clinic baseline visit with assessments\n* Virtual exercise sessions 3 days per week for 4 weeks.\n* IMN supplementation and daily multivitamin starting at 4 weeks of the preoperative phase.\n* Resection surgery per standard of care\n* In-clinic 30 day postoperative visit.",[13],"Behavioral: Prehabilitation Program",{"label":15,"type":16,"description":17,"interventionNames":18},"Group B: Usual Care","NO_INTERVENTION","Participants will be randomized in a 1:1 ratio using a permuted blocked design and stratified by neoadjuvant therapy received. Participants will complete the following:\n\n* In-clinic baseline visit with assessments\n* Resection surgery per standard of care\n* In-clinic 30 day postoperative visit\n* After completion of the study period, participants will be offered exercise equipment with an exercise instruction booklet.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Prehabilitation Program","A hybrid-based, prehabilitation regimen comprised of nutritional optimization (multivitamin and protein supplement shake) and virtual, aerobic and resistance exercise sessions with clinical exercise physiologists. Virtual exercise sessions will be performed via a HIPAA-compliant videoconferencing platform or by phone call. Mini-exercise cycle ergometer, dumbbells, and resistance bands will be provided and delivered to participant. Heart rate monitors and wi-fi enable tablet will be provided if needed.",[9],[26],{"name":27,"affiliation":5,"role":28},"Jeffrey Meyerhardt, MD, MPH","PRINCIPAL_INVESTIGATOR",[30],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","617-632-6855","jeffrey_meyerhardt@dfci.harvard.edu",[35,52],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Boston","Massachusetts","02115","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-71.05977,42.35843,{"lat":46,"lon":45},[49,50],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},{"name":51,"role":28,"phone":18,"phoneExt":18,"email":18},"Jeffrey Meyerhardt, MD",{"facility":53,"status":36,"city":37,"state":38,"zip":54,"country":40,"countryCode":41,"cosmosGeoPoint":55,"geoPoint":57,"contacts":58},"Brigham and Women's Hospital","02215",{"type":43,"coordinates":56},[45,46],{"lat":46,"lon":45},[59,63],{"name":60,"role":31,"phone":61,"phoneExt":18,"email":62},"Joel Goldberg, MD","617-732-8460","JGOLDBERG1@PARTNERS.ORG",{"name":60,"role":28,"phone":18,"phoneExt":18,"email":18},{"type":28,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Jeffrey A. Meyerhardt, MD","Principal Investigator","100559509","the-impact-of-preoperative-exercise-and-nutritional-optimization-on-perioperative-outcomes-for-patients-undergoing-treatment-for-rectal-cancer-the-propel-trial-100559509",false,"NCT06565052","The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial","Inclusion Criteria:\n\n* Age greater than or equal to 18 years at time of enrollment.\n* English-Speaking.\n* Diagnosis of clinical stage II-III rectal cancer.\n* Planned, ongoing or just completed neoadjuvant treatment, including either 1) chemoradiation, 2) total neoadjuvant therapy (TNT), or 3) chemotherapy only; and anticipated surgical resection to follow.\n* Able to understand the study procedures, agree to participate in the study program, and voluntarily provide informed consent.\n\nExclusion Criteria:\n\n* Distant metastatic disease known at the time of diagnosis.\n* Functional incapacity (i.e., incapable of performing exercise testing).\n* Comorbid conditions or cognitive\u002Fphysical impairments that contraindicate exercise.\n* Currently undergoing treatment for a secondary primary tumor, in addition to primary rectal cancer.\n* Currently enrolled in a separate clinical trial that would prohibit them from performing the tasks instructed in this trial.\n* Currently participating in more than 60 minutes of moderate-to-vigorous aerobic exercise per week over the past month. This study targets insufficiently active persons to assess the effect of the described intervention, where additional exercise done regularly will contaminate the intervention effects.","ALL","18 Years",{"count":76,"type":77},40,"ESTIMATED","INTERVENTIONAL",[80],"NA","The purpose of this study is to determine the feasibility of a prehabilitation program for participants diagnosed with rectal cancer undergoing neoadjuvant chemotherapy and\u002For radiation, followed by surgical resection.\n\nThe names of the groups in this research study are:\n\n* Group A: Prehabilitation program\n* Group B: Usual Care",[83,84,85,86],"Rectal Cancer","Colorectal Cancer","Rectal Cancer Stage II","Rectal Cancer Stage III",[83,84,85,86],"2025-11-19",{"date":90,"type":91},"2025-11-24","ACTUAL",{"date":93,"type":91},"2024-12-15",{"date":95,"type":77},"2027-08-07",{"name":5,"class":6},2]